great stock, great potential, bargain price

  1. 445 Posts.
    SIE, like many other BIOTechs have lost their flavour of the month status and are now trading at bargain prices.

    SIE was in the Aegis BlueBook Report OCt 2003 on the Healthcare Sector.

    Has the potential to be a 10 bagger as their drugs for treating diabetes and Hepatitus have enormous worldwide application. Launching products all over the world in the next 1-2 years.

    Potentialy a 10 bagger at these prices!!!!!

    Check out the report for yourself at www.aer.com.au
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.